Results
|
|
81.
|
The efficacy of adenovirus-mediated gene therapy of ovarian cancer is enhanced by using the cytomegalovirus promoter. [electronic resource] by
- Tong, X
- Engehausen, D G
- Freund, C T
- Agoulnik, I
- Guo, Z
- Oehler, M K
- Kim, T E
- Hasenburg, A
- Contant, C F
- Woo, S L
- Kieback, D G
Producer: 19980618
In:
Anticancer research vol. 18
Availability: No items available.
|
|
|
82.
|
Histologic and immunohistochemical analysis of tissue response to adenovirus-mediated herpes simplex thymidine kinase gene therapy of ovarian cancer. [electronic resource] by
- Hasenburg, A
- Fischer, D C
- Tong, X-W
- Rojas-Martinez, A
- Nyberg-Hoffman, C
- Orlowska-Volk, M
- Kohlberger, P
- Kaufman, R H
- Ramzy, I
- Aguilar-Cordova, E
- Kieback, D G
Producer: 20020426
In:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 12
Availability: No items available.
|
|
|
83.
|
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix. [electronic resource] by
- Kudelka, A P
- Verschraegen, C F
- Levy, T
- Edwards, C L
- Fishman, A
- Freedman, R S
- Kaplan, A
- Kieback, D G
- Mante, R
- Ende, K
- Steger, M
- Kavanagh, J J
Producer: 19970115
In:
Anti-cancer drugs vol. 7
Availability: No items available.
|
|
|
84.
|
Multicenter phase II study of oral capecitabine (Xeloda(")) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy. [electronic resource] by
- Reichardt, P
- Von Minckwitz, G
- Thuss-Patience, P C
- Jonat, W
- Kölbl, H
- Jänicke, F
- Kieback, D G
- Kuhn, W
- Schindler, A E
- Mohrmann, S
- Kaufmann, M
- Lück, H J
Producer: 20031017
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 14
Availability: No items available.
|
|
|
85.
|
Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy. [electronic resource] by
- Tong, X W
- Engehausen, D G
- Kaufman, R H
- Agoulnik, I
- Contant, C
- Freund, C T
- Oehler, M K
- Kim, T E
- Hasenburg, A
- Woo, S L
- Kieback, D G
Producer: 19980618
In:
Anticancer research vol. 18
Availability: No items available.
|
|
|
86.
|
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. [electronic resource] by
- O'Brien, M E R
- Wigler, N
- Inbar, M
- Rosso, R
- Grischke, E
- Santoro, A
- Catane, R
- Kieback, D G
- Tomczak, P
- Ackland, S P
- Orlandi, F
- Mellars, L
- Alland, L
- Tendler, C
Producer: 20040712
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 15
Availability: No items available.
|
|
|
87.
|
Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. [electronic resource] by
- Baselga, J
- Rischin, D
- Ranson, M
- Calvert, H
- Raymond, E
- Kieback, D G
- Kaye, S B
- Gianni, L
- Harris, A
- Bjork, T
- Averbuch, S D
- Feyereislova, A
- Swaisland, H
- Rojo, F
- Albanell, J
Producer: 20021119
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 20
Availability: No items available.
|
|
|
88.
|
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. [electronic resource] by
- Wang-Gohrke, S
- Weikel, W
- Risch, H
- Vesprini, D
- Abrahamson, J
- Lerman, C
- Godwin, A
- Moslehi, R
- Olipade, O
- Brunet, J S
- Stickeler, E
- Kieback, D G
- Kreienberg, R
- Weber, B
- Narod, S A
- Runnebaum, I B
Producer: 19990930
In:
British journal of cancer vol. 81
Availability: No items available.
|
|
|
89.
|
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial. [electronic resource] by
- Bartlett, J M S
- Brookes, C L
- Piper, T
- van de Velde, C J H
- Stocken, D
- Lyttle, N
- Hasenburg, A
- Quintayo, M A
- Kieback, D G
- Putter, H
- Markopoulos, C
- Kranenbarg, E M-K
- Mallon, E A
- Dirix, L Y
- Seynaeve, C
- Rea, D W
Producer: 20140220
In:
British journal of cancer vol. 109
Availability: No items available.
|
|
|
90.
|
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix. [electronic resource] by
- Kudelka, A P
- Levy, T
- Verschraegen, C F
- Edwards, C L
- Piamsomboon, S
- Termrungruanglert, W
- Freedman, R S
- Kaplan, A L
- Kieback, D G
- Meyers, C A
- Jaeckle, K A
- Loyer, E
- Steger, M
- Mante, R
- Mavligit, G
- Killian, A
- Tang, R A
- Gutterman, J U
- Kavanagh, J J
Producer: 19990322
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 3
Availability: No items available.
|
|
|
91.
|
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countries. [electronic resource] by
- van Nes, J G H
- Seynaeve, C
- Jones, S
- Markopoulos, C
- Putter, H
- van de Velde, C J H
- Hasenburg, A
- Rea, D W
- Vannetzel, J-M
- Dirix, L
- Hozumi, Y
- Kerin, M J
- Kieback, D G
- Meershoek-Klein Kranenbarg, W M
- Hille, E T M
- Nortier, J W R
Producer: 20100505
In:
The British journal of surgery vol. 97
Availability: No items available.
|
|
|
92.
|
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. [electronic resource] by
- Runnebaum, I B
- Wang-Gohrke, S
- Vesprini, D
- Kreienberg, R
- Lynch, H
- Moslehi, R
- Ghadirian, P
- Weber, B
- Godwin, A K
- Risch, H
- Garber, J
- Lerman, C
- Olopade, O I
- Foulkes, W D
- Karlan, B
- Warner, E
- Rosen, B
- Rebbeck, T
- Tonin, P
- Dubé, M P
- Kieback, D G
- Narod, S A
Producer: 20011226
In:
Pharmacogenetics vol. 11
Availability: No items available.
|